000 01217 a2200325 4500
005 20250515091720.0
264 0 _c20071108
008 200711s 0 0 eng d
022 _a1539-3704
024 7 _a10.7326/0003-4819-147-8-200710160-00013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMulrow, Cynthia D
245 0 0 _aRosiglitazone: a thunderstorm from scarce and fragile data.
_h[electronic resource]
260 _bAnnals of internal medicine
_cOct 2007
300 _a585-7 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aCardiovascular Diseases
_xchemically induced
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xadverse effects
650 0 4 _aMeta-Analysis as Topic
650 0 4 _aMyocardial Infarction
_xchemically induced
650 0 4 _aResearch Design
_xstandards
650 0 4 _aRosiglitazone
650 0 4 _aThiazolidinediones
_xadverse effects
700 1 _aCornell, John
700 1 _aLocalio, A Russell
773 0 _tAnnals of internal medicine
_gvol. 147
_gno. 8
_gp. 585-7
856 4 0 _uhttps://doi.org/10.7326/0003-4819-147-8-200710160-00013
_zAvailable from publisher's website
999 _c17458842
_d17458842